Benefit of Topical Combination Therapy for Acne Treatment: Analysis of Effect Size Using Number Needed to Treat

Steven Feldman; George Han; Valerie Callender; Leon Kircik; Linda Stein Gold; Neal Bhatia; Stephen Tyring; Joshua Zeichner

doi:10.25251/skin.7.supp.211

Steven R Feldman, MD, PhD
George Han, MD, PhD
Valerie Callender, MD
Leon H Kircik, MD
Linda Stein Gold, MD
Neal Bhatia, MD
Stephen K Tyring, MD, PhD
Joshua A Zeichner, MD

Keywords

Acne, Number Needed to Treat, topical, fixed-dose combination, NNT, effect size

References

1. Citrome L, Ketter TA. Int J Clin Pract. 2013;67(5):407-11.

2. Citrome L. J Clin Psychiatry. 2011;72(3):412-3.

3. Manriquez JJ, et al. J Am Acad Dermatol. 2007;56(4):664-71.

4. McAlister FA. CMAJ. 2008;179(6):549-53.

5. Nguyen C, et al. Explor Res Clin Soc Pharm. 2021;2:100039.

6. Drugs@FDA: FDA-Approved Drugs. https://www.accessdata.fda.gov/scripts/cder/daf/

7. Stein Gold L, et al. Presented at the annual American Academy of Dermatology Meeting. March 25-29, 2022.

8. Stein Gold L, et al. Am J Clin Dermatol. 2022;23(1):93-104.

Poster PDF

Published

May 20, 2023

DOI https://doi.org/10.25251/skin.7.supp.211

How to Cite

Feldman, S., Han, G., Callender, V., Kircik, L., Stein Gold, L., Bhatia, N., Tyring, S., & Zeichner, J. (2023). Benefit of Topical Combination Therapy for Acne Treatment: Analysis of Effect Size Using Number Needed to Treat. SKIN The Journal of Cutaneous Medicine, 7(3), s211. https://doi.org/10.25251/skin.7.supp.211

Issue

Vol. 7 No. 3 (2023): May Issue and Posters from WCH23 & WCM23

Section

Acne & Rosacea

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by the following user license:

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

Mark Lebwohl, Andrea Murina, George Han, Abby Jacobson, Brodalumab: 4-Year US Pharmacovigilance Report , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference®
Lawrence F Eichenfield, Linda Stein Gold, Leon Kircik, William P Werschler, Kenneth Beer, Zoe D Draelos, Emil A Tanghetti, Kim Papp, Hilary Baldwin, Edward Lain, Neil Sadick, Eric Guenin, Efficacy and Safety of Triple-Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.1%/Adapalene 0.15% Polymeric Gel in Pediatric Participants with Acne , SKIN The Journal of Cutaneous Medicine: Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference®
Leon Kircik, Jonathan S Weiss, Kent Allenby, DFD-01, a VCA midpotent beteamethasone dipropionate 0.05% emollient-like spray formulation, demonstrates earlier onset of action compared with a super potent topical steroid for the treatment of moderate psoriasis , SKIN The Journal of Cutaneous Medicine: Vol. 1 (2017): Supplemental Issue: Scientific Posters Presented at 2017 Fall Clinical Dermatology Conference®-Las Vegas
Linda Stein Gold, Sunil Dhawan, Jonathan Weiss, Zoe D Draelos, Herman Ellman, The Efficacy and Safety of FMX101, Minocycline Foam 4%, for the Treatment of Acne Vulgaris: A Pooled Analysis of Phase 2 and Phase 3 Studies , SKIN The Journal of Cutaneous Medicine: Vol. 2 (2018): Supplemental Issue: Scientific Posters Presented at 2018 Winter Clinical Dermatology Conference®-Hawaii
Tiffany Mayo, April Armstrong, Leon Kircik, Jonathan Silverberg, Andrew Blauvelt, Ben Esdaile, Shannon Schneider, Thomas Mark, Melinda Gooderham, Andrew Alexis, Efficacy and safety of up to two years of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference®
Andrew Blauvelt, Linda Stein Gold, Melinda Gooderham, Bruce Strober, Andreas Pinter, Jose-Manuel Carrascosa, Paolo Gisondi, Jonathan Bleier, Cynthia Madden, Delphine Deherder, Natalie Nunez Gomez, Richard B Warren, Bimekizumab efficacy and safety through two years in patients with moderate psoriasis: Analysis of pooled data from five phase 3/3b clinical trials , SKIN The Journal of Cutaneous Medicine: Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference®
Zoe D. Draelos, MD, Emil A. Tanghetti, MD, Linda Stein Gold, MD, Leon H Kircik, MD, Neal Bhatia, MD, Joshua A. Zeichner, MD, Jeffrey L. Sugarman, MD, PhD, Dermal Irritation, Sensitization, and Safety of Fixed-Dose Triple-Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.1%/Adapalene 0.15% Gel in Healthy Participants , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 4 (2023): July Issue & Posters from FCPANP 23
Julie C Harper, MD, Leon H Kircik, MD, Michael Gold, MD, Adelaide A Hebert, MD, Jeffrey L Sugarman, MD, PhD, Lawrence Green, MD, Linda Stein Gold, MD, Hilary Baldwin, MD, James Q Del Rosso, DO, Eric Guenin, PharmD, PhD, MPH, Early and Sustained Reductions in Moderate-to-Severe Acne With Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 3 (2023): May Issue and Posters from WCH23 & WCM23
Diamant Thaçi, Mark Lebwohl, Richard B. Warren, Leon Kircik, Subhashis Banerjee, Andrew Napoli, Renata M. Kisa, Misti Linaberry, Kim Hoyt, Andrew Blauvelt, Deucravacitinib Long-term Efficacy With Continuous Treatment in Plaque Psoriasis: 2-Year Results From the Phase 3 POETYK PSO-1 and PSO-2 Trials , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 6 (2023): November 2023 Issue
Tiffany Mayo, April W Armstrong, Leon Kircik, Jonathan Silverberg, Andrew Blauvelt, Ben Esdalie, Shannon Schneider, Thomas Mark, Melinda Gooderham, Andrew F Alexis, Efficacy and safety of up to two years of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis , SKIN The Journal of Cutaneous Medicine: Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference®

<< < 7 8 9 10 11 12 13 14 15 16 > >>

Main Article Content

Keywords

References

Article Sidebar

Article Details

Most read articles by the same author(s)